Major Depressive Disorder and Management of Population Health
Release Date: June 29, 2018
Expiration Date: June 29, 2019
Media: Internet - based
The behavioral health care landscape is evolving and healthcare professionals are becoming more aware of the need to improve patient care and adherence to treatment. This activity examines the prevalence of major depressive disorder and the diversity of treatment options. The role played by accountable care organizations in helping to enhance the quality of life of patients experiencing this condition will also be highlighted.
Instructions for This Activity and Receiving Credit
Physicians, pharmacists, and managed care professionals
- Determine the prevalence of depression while describing the disparities in care and disabilities associated
- Illustrate prohibitive treatment modalities that exist within major depressive disorder and how accountable care organizations are working to improve patient care
- Apply the successes and failures of depression treatment within the private and public sectors, including how adherence to medications is being addressed
Faculty, Staff, and Planners' Disclosures
Roger Kathol, MD
President, Cartesian Solutions, Inc.
University of Minnesota
Disclosure: Consultant/Stock-Shareholder: Cartesian Solutions, Inc.
The staff of PER® have no relevant financial relationships with commercial interests to disclose.
Disclosure Policy and Resolution of Conflicts of Interest (COI)
As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.
Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.
March 27, 2021
November 27, 2020
November 15, 2019